Goobye injections? Eli Lilly is developing ‘Orforglipron pills’ for weight loss and type 2 diabetes , and it could be a gamechanger

A new oral medication, Orforglipron, is set to revolutionize weight loss and diabetes management, offering a pill alternative to GLP-1 injections. Developed by Eli Lilly, this drug mimics natural hormones to curb appetite and slow digestion, showing significant weight loss in trials. Expected to be more accessible and affordable, it promises a new era for those battling obesity. Read below!